US Stock MarketDetailed Quotes

NVCR Novocure

Watchlist
  • 12.635
  • +0.405+3.31%
Close Apr 26 16:00 ET
  • 12.550
  • -0.085-0.67%
Post 19:46 ET
1.36BMarket Cap-6479P/E (TTM)

About Novocure Company

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Company Profile

SymbolNVCR
Company NameNovocure
Listing DateOct 2, 2015
Issue Price22.00
Founded2000
CEOMr. Asaf Danziger
MarketNASDAQ
Employees1453
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressNo. 4 The Forum,Grenville Street,2nd Floor
CitySt. Helier
ProvinceJersey
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeJE2 4UF
Phone44-15-3475-6700
Websitehttp://www.novocure.com

Company Executives

  • Name
  • Position
  • Salary
  • Asaf Danziger
  • Chief Executive Officer and Director
  • 1.52M
  • Wilhelmus C. M. Groenhuysen
  • Chief Operating Officer
  • 5.97M
  • Michae Puri
  • Chief Human Resources Officer
  • --
  • Moshe Giladi
  • Chief Science Officer
  • --
  • Dr. Nicholas Leupin, M.D.,PhD
  • Chief Medical Officer
  • --
  • Dr. Uri Weinberg, M.D.,PhD
  • Chief Innovation Officer
  • --
  • Ashley Cordova
  • Chief Financial Officer and Principal Accounting Officer
  • 6.32M
  • Francis Leonard
  • Executive Vice President and President
  • 5.04M
  • William F. Doyle
  • Executive Chairman of the Board
  • 1.43M
  • Kristin Stafford, C.P.A.
  • Director
  • 696.94K
  • Dr. Allyson J. Ocean, M.D.
  • Independent Director
  • 697.26K
  • Timothy John Scannell
  • Independent Director
  • 448.53K
  • Kinyip Gabriel Leung
  • Independent Director
  • 435.53K
  • Martin J. Madden
  • Independent Director
  • 446.09K
  • William A. Vernon
  • Lead Independent Director
  • 475.53K
  • Dr. David T. Hung,M.D.
  • Independent Director
  • 426.09K
  • Jeryl L. Hilleman
  • Independent Director
  • 446.09K
  • Barak Ben-Arye
  • General Counsel
  • 4.86M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg